Pharmacare, patient groups, and the need for open discourse

Canada needs a universal, national, publicly funded pharmacare program, which would improve drug safety and effectiveness.

Canada's federal Health Minister Patty Hajdu, pictured Dec. 11, 2020, is tasked with taking steps towards a national pharmacare program. Professor Sharon Batt writes that with industry-funded patient groups advocating against it, will it ever become a reality? The Hill Times photograph by Andrew Meade

Opinion

BY SHARON BATT

February 8, 2021

Will Canadians ever have the universal national pharmacare program that repeated investigations show will support fair, appropriate health care and that 86 per cent of Canadians say they want? The long-simmering question is once again on the minds of voters. In his sup...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Weekend Point of View Newsletter

A round up of the past weekâ€™s opinion writers and columnists on Saturdays and Sundays.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy